Why the study?
Do synthetic peptides from poliovirus type 1 capsid protein VP1 induce neutralizing antibodies in rabbits and rats?
Do synthetic peptides from poliovirus type 1 capsid protein VP1 induce neutralizing antibodies in rabbits and rats?
Synthetic peptides from specific noncontiguous regions of poliovirus type 1 VP1 can induce neutralizing antibodies, defining the neutralizing determinants of the protein.
Answers are grounded in this paper and cite their sources.
Defines VP1 neutralizing epitopes in animal models; leaves open translation to human polio vaccines.
Peptides from different regions of the poliovirus type 1 capsid protein VP1 were synthesized. Antibodies raised against these peptides in rabbits and rats recognized the cognate peptides and denatured VP1. Peptides from four regions of VP1 generated antisera with neutralizing titers specifically against poliovirus type 1. Antisera against all other regions of VP1 failed to neutralize virus infectivity, although some of the antisera clearly bound to native virions. Thus, the neutralizing determinants on VP1 reside in specific noncontiguous regions of the protein and can be defined by specific peptides from these regions.
No takes yet. Share an insight, caveat, or question.
Chow et al. (1985) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: